Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
981 to 1,000 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R21HD102565 | Peripheral Immune Development in Premature Infants with and without NEC | 2 | 2021 |
| U19AI111224 | Metabolic factors that control the spectrum of human tuberculosis | 2 | 2021 |
| U19AI128913 | Mapping Immune Responses to CMV in Renal Transplant Recipients | 2 | 2021 |
| ZIAES102345 | Massive Genome Informatics | 2 | 2021 |
| F31AI147638 | Investigating a disintegrin and metalloproteinase-mediated Neuropilin 1 cleavage in autoimmune diabetes | 1 | 2021 |
| F31HD107807 | The Role of Progesterone Receptor in the Oviduct Epithelium for Pregnancy Establishment | 1 | 2021 |
| F31HL147364 | Role of interleukin-3 in autoimmune and viral myocarditis | 1 | 2021 |
| F31NS116912 | Understanding the immune response after mild TBI: Do endothelial cells play a major role? | 1 | 2021 |
| K00CA234923 | The role of T helper cells in mediating effective immune checkpoint blockade therapy against cancer | 1 | 2021 |
| K01AR072773 | Breaking down barriers: defining the role of EphA2 in building epidermal tight junctions in atopic dermatitis | 1 | 2021 |
| K08HL143127 | Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles | 1 | 2021 |
| K23HL135398 | Effects of Bariatric Surgery on HDL and Platelet Function | 1 | 2021 |
| K23HL138291 | Investigating the role of the JAK/STAT3 Pathway in Clonal Proliferation and Immune Dysfunction in Myelodysplastic Syndrome | 1 | 2021 |
| K99AG065484 | Quantitating, Targeting, and Phenotyping In Vivo Cellular Senescence in Humans | 1 | 2021 |
| K99CA241072 | Exploring the impact of HSP90 inhibition on antigen presentation and anti-tumor immune responses | 1 | 2021 |
| K99DE028573 | Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | 1 | 2021 |
| K99NS120278 | Spatial Regulators of Skeletal Muscle Regeneration and Disease | 1 | 2021 |
| P01AI060699 | PPG: SARS-CoV-host cell interactions and vaccine development | 1 | 2021 |
| P01CA069246 | Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas | 1 | 2021 |
| P01CA154303 | Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=50